Effect of green tea extract on reactive oxygen species produced by neutrophils from cancer patients

Anticancer Research

Volumn 32, Issue 6, 2012, Pages 2369-2375

  Suzuki, Katsuhiko ^a,b   Ohno, Satoshi ^a,c   Suzuki, Yoko ^a,b   Ohno, Yumiko ^a   Okuyama, Ryuji ^c   Aruga, Atsushi ^c   Yamamoto, Masakazu ^c   Ishihara, Ken O ^d   Nozaki, Tsutomu ^d   Miura, Shigeki ^e   Yoshioka, Hiroshi ^e   Mori, Yuichi ^e  

^a WASEDA UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d BHN Co Ltd   (Japan)

^e Mebiol Inc   (Japan)

Author keywords

Cancer; Green tea; Inflammation; Luminol dependent chemiluminescence; Neutrophil; Oxidative stress; Reactive oxygen species

Indexed keywords

GREEN TEA EXTRACT; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT; PLANT EXTRACT;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PATIENT; CELL MIGRATION; CONCENTRATION RESPONSE; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUTROPHIL; PRIORITY JOURNAL; CHEMISTRY; LUMINESCENCE; METABOLISM; MIDDLE AGED; NEOPLASM; OXIDATIVE STRESS; TEA;

ADULT; AGED; ANTIOXIDANTS; CAMELLIA SINENSIS; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPHILS; OXIDATIVE STRESS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; TEA;

EID: 84864555821     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S and Croce CM: Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci 108 : 4908-4913, 2011.
2. Coussens LM and Werb Z: Inflammation and cancer. Nature 420 : 860-867, 2002.
3. Wang H, Lai YJ, Chan YL, Li TL and Wu CJ: Epigallocatechin- 3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia. Cancer Lett 305 : 40-49, 2011.
4. Gupta SC, Kim JH, Kannappan R, Reuter S, Dougherty PM and Aggarwal BB: Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med 236 : 658-671, 2011.
5. Suzuki Y, Ohno S, Okuyama R, Aruga A, Yamamoto M, Miura S, Yoshioka H, Mori Y and Suzuki K: Determination of chronic inflammatory states in cancer patients using assay of reactive oxygen species production by neutrophils. Anticancer Res 32: 565-570, 2012.
6. Mantovani G, Macciò A, Madeddu C, Gramignano G, Serpe R, Massa E, Dessì M, Tanca FM, Sanna E, Deiana L, Panzone F, Contu P and Floris C: Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 24: 305-313, 2008.
7. Mantovani G, Macciò A, Madeddu C, Serpe R, Antoni G, Massa E, Dessì M and Panzone F: Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. J Mol Med 88 : 85-92, 2010.
8. Wiedenmann B, Malfertheiner P, Friess H, Ritch P, Arseneau J, Mantovani G, Caprioni F, Van Cutsem E, Richel D, DeWitte M, Qi M, Robinson D Jr., Zhong B, De Boer C, Lu JD, Prabhakar U, Corringham R and Von Hoff D: A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. J Support Oncol 6 : 18-25, 2008.
9. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland KM Jr., Camoriano JK, Novotny PJ and Christensen BJ: Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 17: 3299-3306, 1999.
10. Macciò A, Madeddu C, Gramignano G, Mulas C, Floris C, Sanna E, Cau MC, Panzone F and Mantovani G: A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecol Oncol 124: 417-425, 2012.
11. Ellis LZ, Liu W, Luo Y, Okamoto M, Qu D, Dunn JH and Fujita M: Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion. Biochem Biophys Res Commun 414: 551-556, 2011.
12. Khan N, Adhami VM and Mukhtar H: Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer 61: 836-841, 2009.
13. Zhu J, Wang O, Ruan L, Hou X, Cui Y, Wang JM and Le Y: The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. Int Immunopharmacol 9: 1126-1130, 2009.
14. Hasegawa H, Suzuki K, Nakaji S and Sugawara K: Analysis and assessment of the capacity of neutrophils to produce reactive oxygen species in a 96-well microplate format using lucigeninand luminol-dependent chemiluminescence. J Immunol Methods 210: 1-10, 1997.
15. Sudha B, Madhavan HN, Sitalakshmi G, Malathi J, Krishnakumar S, Mori Y, Yoshioka H and Abraham S: Cultivation of human corneal limbal stem cells in Mebiol Gel - A thermo-reversible gelation polymer. Indian J Med Res 124: 655-664, 2006.
16. Kawai Y, Matsui Y, Kondo H, Morinaga H, Uchida K, Miyoshi N, Nakamura Y and Osawa T: Galloylated catechins as potent inhibitors of hypochlorous acid-induced DNA damage. Chem Res Toxicol 21 : 1407-1414, 2008.
17. Kürbitz C, Heise D, Redmer T, Goumas F, Arlt A, Lemke J, Rimbach G, Kalthoff H and Trauzold A: Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells. Cancer Sci 102 : 728-734, 2011.
18. Gutierrez-Orozco F, Stephens BR, Neilson AP, Green R, Ferruzzi MG and Bomser JA: Green and black tea inhibit cytokine-induced IL-8 production and secretion in AGS gastric cancer cells via inhibition of NF- κB activity. Planta Med 76: 1659-1665, 2010.
19. Khan N, Afaq F and Mukhtar H: Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 10: 475-510, 2008.
20. Khan N and Mukhtar H: Tea polyphenols for health promotion. Life Sci 81: 519-533, 2007.
21. Romaschin AD, Foster DM, Walker PM and Marshall JC: Let the cells speak: Neutrophils as biologic markers of the inflammatory response. Sepsis 2 : 119-125, 1998.